Several signaling pathways, including PI3 K/Akt, Wnt/β-catenin, and Notch pathways, are associated with CSCs to help regulate prostate cancer self-renewal, tumor initiation, and chemoresistance (Ni et al. 2014; Cai et al. 2020). This evidence concerns the gene AKT1 and prostate cancer.